| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.1M | +12.0% |
| SG&A Expense | $5.7M | +307.3% |
| Operating Income | -$11.9M | -54.8% |
| Net Income | -$11.7M | -28.2% |
| EPS (Basic) | -$7.16 | -124.5% |
| EPS (Diluted) | -$7.16 | -117.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $334K | -82.6% |
| Current Assets | $503K | -77.3% |
| Total Assets | $10.5M | +318.0% |
| Current Liabilities | $8.0M | +419.4% |
| Total Liabilities | $8.2M | +357.5% |
| Stockholders' Equity | $2.3M | +217.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.5M | -29.4% |
| Investing Cash Flow | -$3.1M | -204.8% |
| Financing Cash Flow | $11.0M | +191.7% |